0001209191-17-046056.txt : 20170724 0001209191-17-046056.hdr.sgml : 20170724 20170724135529 ACCESSION NUMBER: 0001209191-17-046056 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170724 DATE AS OF CHANGE: 20170724 EFFECTIVENESS DATE: 20170724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trovagene, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043721895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291358 FILM NUMBER: 17978074 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-217-5420 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 FORMER COMPANY: FORMER CONFORMED NAME: USED KAR PARTS INC DATE OF NAME CHANGE: 20030106 D 1 primary_doc.xml X0708 D LIVE 0001213037 Trovagene, Inc. 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 858-217-4838 DELAWARE None TrovaGene Inc. XENOMICS INC USED KAR PARTS INC Corporation true Thomas Adams 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Director William Welch 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Executive Officer Director Rodney Markin 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Director John Brancaccio 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Director Gary Jacob 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Director Paul Billings 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Director Stanley Tennant 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Director Mark Erlander 11055 Flintkote Avenue, Suite B San Diego CA CALIFORNIA 92121 Executive Officer Biotechnology $1 - $1,000,000 06b false 2017-07-19 false true true false 0 Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 CA CALIFORNIA NJ NEW JERSEY NY NEW YORK 6547512 0 6547512 Represents aggregate exercise price of warrants to purchase 4,643,625 shares of the Company's common stock, which were issued in connection with an offering of 6,191,500 shares of the Company's common stock issued in a registered direct offering. false 4 427214 50000 $427,214 is for a fee of 6.00% of the gross proceeds from the sale of securities in the private placement of warrants and concurrent registered direct offering, and $50,000 is for the reimbursement of expenses incurred by the placement agents. 0 false Trovagene, Inc. /s/ William Welch William Welch Chief Executive Officer 2017-07-24